Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples